Page last updated: 2024-08-23

brimonidine tartrate and aspartic acid

brimonidine tartrate has been researched along with aspartic acid in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akbarali, H; Horstman, DA; Limbird, LE; Surprenant, A1
Brandon, S; Cragoe, EJ; Guyer, CA; Horstman, DA; Limbird, LE; Wilson, AL1
Lakhlani, PP; Limbird, LE; Lovinger, DM1
Donello, JE; Gil, DW; Padillo, EU; Webster, ML; Wheeler, LA1

Other Studies

4 other study(ies) available for brimonidine tartrate and aspartic acid

ArticleYear
A point mutation of the alpha 2-adrenoceptor that blocks coupling to potassium but not calcium currents.
    Science (New York, N.Y.), 1992, Aug-14, Volume: 257, Issue:5072

    Topics: Adrenergic alpha-Agonists; Animals; Asparagine; Aspartic Acid; Brimonidine Tartrate; Calcium Channels; Cell Line; Clonidine; GTP-Binding Proteins; Membrane Potentials; Mutagenesis, Site-Directed; Potassium Channels; Quinoxalines; Receptors, Adrenergic, alpha; Receptors, Neurotransmitter; Receptors, Somatostatin; Recombinant Proteins; Somatostatin; Transfection

1992
An aspartate conserved among G-protein receptors confers allosteric regulation of alpha 2-adrenergic receptors by sodium.
    The Journal of biological chemistry, 1990, Dec-15, Volume: 265, Issue:35

    Topics: Affinity Labels; Allosteric Regulation; Amino Acid Sequence; Animals; Aspartic Acid; Brimonidine Tartrate; Dioxanes; DNA Mutational Analysis; Epinephrine; Idazoxan; In Vitro Techniques; Molecular Sequence Data; Oxymetazoline; Prazosin; Quinoxalines; Receptors, Adrenergic, alpha; Sodium; Structure-Activity Relationship; Swine; Transfection; Yohimbine

1990
Genetic evidence for involvement of multiple effector systems in alpha 2A-adrenergic receptor inhibition of stimulus-secretion coupling.
    Molecular pharmacology, 1996, Volume: 50, Issue:1

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenocorticotropic Hormone; Analysis of Variance; Animals; Asparagine; Aspartic Acid; Barium; Brimonidine Tartrate; Calcium Channels; Cell Line; GTP-Binding Proteins; Isoproterenol; Mutagenesis, Site-Directed; Patch-Clamp Techniques; Pituitary Gland, Anterior; Point Mutation; Potassium Channels; Quinoxalines; Receptors, Adrenergic, alpha-2; Recombinant Proteins; Somatostatin

1996
alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:1

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aspartic Acid; Brimonidine Tartrate; Chromatography, Liquid; Electroretinography; Extracellular Space; Glutamic Acid; Ischemia; Male; Mass Spectrometry; Quinoxalines; Rats; Rats, Inbred BN; Retina; Retinal Ganglion Cells; Retinal Vessels; Vitreous Body; Yohimbine

2001